» Articles » PMID: 37248865

Hypoxia-responsive LncRNA G077640 Promotes ESCC Tumorigenesis Via the H2AX-HIF1α-glycolysis Axis

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2023 May 30
PMID 37248865
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) contribute to esophageal squamous cell carcinoma (ESCC) progression, but the underlying mechanisms remain elusive. In this study, we verified a hitherto uncharacterized hypoxia-responsive lncRNA, G077640, which is upregulated in human ESCC cells and tissues, supporting the proliferation and migration of ESCC cells. Mechanistically, G077640 prevented hypoxia-inducible factor-1α (HIF1α) from being degraded by directly interacting with histone H2AX and further modulated the interaction of HIF1α and H2AX. In addition, G077640 reprogrammed glycolytic metabolism by regulating the expression of glucose transporter 4 (GLUT4), hexokinase 2 (HK2) and pyruvate dehydrogenase kinase 1 (PDK1) for ESCC proliferation and migration. Clinically, G077640 was associated with poor prognosis in ESCC patients. Taken together, our findings identified a hypoxia-responsive lncRNA that contributes to ESCC cells proliferation and migration, and targeting G077640 and its pathway might be a potential therapeutic strategy for ESCC.

Citing Articles

Pharmacological Modulation of Mutant with Oncotargets Against Esophageal Cancer and Therapy Resistance.

Lin P, Lee Y, Chen I, Chung H Biomedicines. 2025; 13(2).

PMID: 40002862 PMC: 11852872. DOI: 10.3390/biomedicines13020450.


Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies.

Dong X, Chen L, Xu Y, Wu P, Xie T, Liu Z Cancer Gene Ther. 2025; 32(2):165-183.

PMID: 39794467 DOI: 10.1038/s41417-024-00858-5.


Long noncoding RNA steroid receptor RNA activator 1 inhibits proliferation and glycolysis of esophageal squamous cell carcinoma.

He M, Qi Y, Zheng Z, Sha M, Zhao X, Chen Y World J Gastrointest Oncol. 2024; 16(10):4194-4208.

PMID: 39473951 PMC: 11514674. DOI: 10.4251/wjgo.v16.i10.4194.


Hypoxia promotes histone H3K9 lactylation to enhance transcription in esophageal squamous cell carcinoma.

Zang Y, Wang A, Zhang J, Xia M, Jiang Z, Jia B iScience. 2024; 27(7):110188.

PMID: 38989468 PMC: 11233973. DOI: 10.1016/j.isci.2024.110188.


Metabolic reprogramming in esophageal squamous cell carcinoma.

Wang Z, Sun X, Li Z, Yu H, Li W, Xu Y Front Pharmacol. 2024; 15:1423629.

PMID: 38989149 PMC: 11233760. DOI: 10.3389/fphar.2024.1423629.